Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis

Lee, JK; Yoon, CS; Na, YO; Park, HK; Oh, HJ; Kho, BG; Park, HY; Kim, TO; Shin, HJ; Kwon, YS; Kim, YI; Lim, SC

Shin, HJ (通讯作者),42 Jebong Ro, Gwangju 61469, South Korea.

JOURNAL OF THORACIC DISEASE, 2023; 15 (1): 65

Abstract

Background: Hemocoagulase batroxobin is used to prevent hemostasis or bleeding in surgical and trauma patients; however, the role of batroxobin in pat......

Full Text Link